For Use In: Dogs of all
Percorten-V is sometimes used off-label to treat Addison's
Disease in cats. Consult your veterinarian about such a use if your
cat has this condition. Do not administer Percorten-V injections
to an animal to which it was not prescribed.
Keep out of reach of children. Do not
allow children to administer Percorten-V. Review package directions
and precautionary statements before use. Follow prescription precisely.
Injections are made intramuscularly,
not intravenously. Ask your veterinarian for instructions on administering
- Shake individual vial vigorously
- Administer Percorten-V injections
exactly as instructed by your veterinarian.
- Typical dosage begins at
1 mg per lb. Dosages are adjusted by your veterinarian according to
electrolyte levels in the blood.
- Inject the medication into
the dog's muscle, and never into a vein. Injection of Percorten-V into
a vein can cause acute collapse and shock. This requires immediate treatment
with intravenous fluids and glucocorticoids.
Frequency of Use:
Administer Percorten-V as prescribed.
Usually, injections are given once every 25 days. Percorten-V does not
cure Canine Addison's Disease, so treatments are continued for the animal's
lifetime. Contact your veterinarian if you miss a dose. Do not administer
a double dose.
Store in original container and out
of reach of children and animals.
Store Percorten-V at room temperature,
ideally between 56 and 89 degrees F. Protect from light and do not allow
product to freeze.
It is a violation of Federal Law
to use this product in a manner inconsistent with its labeling.
The desoxycorticosterone pivalate in
Percorten-V replaces depleted mineralocorticoid steroids in dogs with
Canine Addison's Disease to promote healthy electrolyte balances and
prevents buildup of toxic substances in their bloodstream.
Percorten-V is available by prescription
from your veterinarian.
Injectable Suspension Ingredients:
Multiple-Dose Vials, 4 ml, each ml containing 25 mg desoxycorticosterone
pivalate (DOCP), 10.5 mg methylcellulose, 3 mg sodium carboxymethylcellulose,
1 mg polysorbate 80, and 8 mg sodium chloride with 0.002% thimerosal
added as preservative in water for injection. Packed one vial per carton.
Keep this product out of reach of children
and animals. Do not use or store in or near open flame or heat.
Do not mix Percoten-V with other injectable
Percoten-V is intended only for use
in dogs with Canine Addison's disease. It is not a cure, but a medication
for managing symptoms.
CAUTION: Because of the risk
of interactions, consult your veterinarian before giving your dog vitamins
or supplements, diuretics, insulin, digitalis, aspirin, amphotericin
Side effects of Percorten-V include
diarrhea, loss of appetite, vomiting, weakness, incontinence, and weight
loss. Pain, irritation, infection, or abscesses at the injection site
are also possible. Consult your veterinarian as soon as possible if
you notice side effects in your dog.
Intravenous (IV), rather than intramuscular
(IM) injection requires prompt medical treatment.
Do not administer to pregnant animals
unless benefits outweigh the risks. Percorten-V is not for use in dogs
with congestive heart failure, kidney disease, or edema (swelling).
Not for use in animals allergic to it or drugs similar to it.
Increased drinking and urination, weight
gain, edema, and high blood pressure may indicate an overdose. Consult
your veterinarian right away if you suspect or know of an overdose.
Rule out primary renal disease before
starting therapy with Percorten-V.
Warranty and Manufacturer Information:
Seller makes no warranty, expressed
or implied, concerning the use of this product other than indicated
on the label. Buyer assumes all risk of use and handling of this material
when such use and handling are contrary to label instructions.
Manufactured for: Novartis Animal Health
US, Inc. Greensboro, NC 27408, USA
NADA # 141-029, Approved by FDA.
© 2001 Novartis
PERCORTEN-V is a registered trademark
of Novartis AG.
NAC No.: 11310044